Table 1.
Asthma (n = 26) | Control (n = 15) | p value | |
---|---|---|---|
Gender, Female, n (%) | 20 (77%) | 9 (60%) | 0.17 |
Age (SD) | 48.00 (13.89) | 40.71 (11.40) | 0.10 |
Race | 0.01 | ||
White, n (%) | 22 (84.6) | 11 (73.3) | |
Black, n (%) | 4 (16) | 0 | |
Asian, n (%) | 0 | 4 (26.7) | |
Allergic rhinitis, n (%) | 24 (92) | 3 (20.0) | < 0.001 |
Age at asthma diagnosis (SD) | 25.88 | (18.43) | |
Current ICS use, n (%) | 24 (92) | ||
Used systemic steroid in past year, n (%) | 14 (56%) | ||
Average courses of systemic steroid in past year (SD) | 2.8 (3.1) | ||
ACT score (SD) | 18.9 (4.2) | ||
FEV1 percent predicted (SD) | 92.60 (13.64) | ||
FEV1/FVC percent predicted (SD) | 96.56 (10.43) |
ICS = inhaled corticosteroid steroid.